221 related articles for article (PubMed ID: 19659608)
21. Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.
Hiros M; Spahović H; Selimović M; Sadović S
Bosn J Basic Med Sci; 2008 May; 8(2):147-51. PubMed ID: 18498265
[TBL] [Abstract][Full Text] [Related]
22. Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ≤100 ng/ml.
Çalışkan S
J Cancer Res Ther; 2018; 14(6):1256-1259. PubMed ID: 30488840
[TBL] [Abstract][Full Text] [Related]
23. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
Tang S; Hao H; Fang D; Zheng W; Ge P; Su X; He Q; Yang X; Shen Q; Li X; Yu W; Lin J; Zhou L
Int Braz J Urol; 2018; 44(2):258-266. PubMed ID: 29219277
[TBL] [Abstract][Full Text] [Related]
25. Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen.
Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Horninger W; Klocker H; Mikolajczyk SD
J Urol; 2004 Jun; 171(6 Pt 1):2239-44. PubMed ID: 15126794
[TBL] [Abstract][Full Text] [Related]
26. Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?
Gakis G; Stenzl A; Renninger M
Scand J Urol; 2013 Oct; 47(5):358-62. PubMed ID: 23078550
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
Thompson IM; Pauler DK; Goodman PJ; Tangen CM; Lucia MS; Parnes HL; Minasian LM; Ford LG; Lippman SM; Crawford ED; Crowley JJ; Coltman CA
N Engl J Med; 2004 May; 350(22):2239-46. PubMed ID: 15163773
[TBL] [Abstract][Full Text] [Related]
28. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features.
Krumholtz JS; Carvalhal GF; Ramos CG; Smith DS; Thorson P; Yan Y; Humphrey PA; Roehl KA; Catalona WJ
Urology; 2002 Sep; 60(3):469-73; discussion 473-4. PubMed ID: 12350486
[TBL] [Abstract][Full Text] [Related]
30. An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer.
Gohji K; Nomi M; Kizaki T; Morisue K; Okamoto M; Takenaka A; Fujii A
Br J Urol; 1997 Apr; 79(4):602-7. PubMed ID: 9126092
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.
Zhu YP; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Shi GH
Asian J Androl; 2009 Jan; 11(1):104-8. PubMed ID: 19050682
[TBL] [Abstract][Full Text] [Related]
32. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of high-grade or insignificant prostate cancer in Korean men with prostate-specific antigen levels of 3.0-4.0 ng/mL.
Choi SK; Song C; Shim M; Min GE; Park J; Jeong IG; Hong JH; Kim CS; Ahn H
Urology; 2015 Mar; 85(3):610-5. PubMed ID: 25586476
[TBL] [Abstract][Full Text] [Related]
34. [Histological characteristics and clinical significance of Japanese prostate cancer with low levels of prostate specific antigen of 4.0 ng/ml or lower].
Satoh T; Egawa S; Ohori M; Matsumoto K; Kuwao S; Yanagimoto K; Iwamura M; Uchida T; Baba S
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):429-35. PubMed ID: 10349301
[TBL] [Abstract][Full Text] [Related]
35. Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: a multicenter retrospective analysis.
Ozgür BC; Köseoğlu E; Arık Aİ; Sarıcı H; Bilgin O; Yücetürk CN; Ozer E; Güven EO; Telli O; Atan A; Eroğlu M
Kaohsiung J Med Sci; 2014 Jul; 30(7):371-5. PubMed ID: 24924843
[TBL] [Abstract][Full Text] [Related]
36. Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies.
Vijayakumar S; Quadri SF; Sen S; Vaida F; Ignacio L; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):189-95. PubMed ID: 7536721
[TBL] [Abstract][Full Text] [Related]
37. Tumor Location and Pathological Features of Latent and Incidental Prostate Cancer in Contemporary Japanese Men.
Inaba H; Kimura T; Onuma H; Sato S; Kido M; Yamamoto T; Fukuda Y; Takahashi H; Egawa S
J Urol; 2020 Aug; 204(2):267-272. PubMed ID: 32068492
[TBL] [Abstract][Full Text] [Related]
38. Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.
Nevoux P; Ouzzane A; Ahmed HU; Emberton M; Montironi R; Presti JC; Villers A
BJU Int; 2012 Aug; 110(4):517-23. PubMed ID: 22192756
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of PSA screening in outpatients with bladder cancer: preliminary results.
Kurokawa K; Suzuki K; Okazaki H; Ito K; Shiono A; Fukabori Y; Yamanaka H
Int J Urol; 2002 May; 9(5):237-40. PubMed ID: 12060434
[TBL] [Abstract][Full Text] [Related]
40. Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer.
Winfield HN; Reddy PK; Lange PH
Urology; 1987 Aug; 30(2):100-1. PubMed ID: 3617289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
